Business Development

Our Focus

We are focused on building a differentiated portfolio of transformational therapeutics for patients with serious and life-threatening diseases. We focus on a number of therapeutic disease areas, drug platforms, and technologies.


  • Large and small molecules with differentiated efficacy for the treatment of autoimmune and autoinflammatory conditions
  • Application of innovative approaches (eg, chimeric autoantigen receptor T cells or gene therapy) to¬†autoimmune and autoinflammatory conditions
  • Tolerance induction
  • Local application of systemically validated mechanisms
  • Biomarker-based approaches to stratifying patients within larger heterogeneous diseases
  • Combination therapeutics

Photo of stethoscope


  • Large and small molecules with the potential for differentiated efficacy for the treatment of orphan/niche cardiovascular diseases
  • Innovative approaches to orphan/niche cardiovascular diseases

Photo of hands spreading lotion


  • Antipruritic therapeutics
  • Application of innovative approaches to treat various skin diseases (eg, gene therapy)
  • Large and small molecules with differentiated efficacy for the treatment of dermatological conditions (outside of immunomodulatory approaches)


  • Highly differentiated discovery platforms
  • Rapid development potential from concept to IND
  • Bioinformatic approaches to identify potential disease targets or responder populations

Partner With Us

We have a track record of successful scientific and development collaborations that demonstrate speed, collaboration, innovation, and strong partner relationships.

We have collaborated with partners to acquire the rights to 4 compounds currently in development and are keenly interested in continuing to acquire and develop novel, differentiated programs and platforms.